Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults

NCT02165267 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: VRC01
BIOLOGICAL: SC placebo for VRC01
BIOLOGICAL: IV placebo for VRC01

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)